Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.

Lee M Jampol, Adam R Glassman, Neil M Bressler

Journal: JAMA ophthalmology 2015;133(9):983-4

PMID: 26087135

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Jaeb Center for Health Research, Tampa, Florida.; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland4Editor in Chief, JAMA Ophthalmology.

DOI: 10.1001/jamaophthalmol.2015.1880

Link outs

Free resources

Full Text Sources:

Medical:

Other Literature Sources:

https://scite.ai/reports/26087135

Subscription / membership required

Full Text Sources:

MeSH Terms: Angiogenesis Inhibitors, Bevacizumab, Diabetic Retinopathy, Fees and Charges, Humans, Insurance, Health, Reimbursement, Intravitreal Injections, Macular Edema, Medicare, Randomized Controlled Trials as Topic, Ranibizumab, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Treatment Outcome, United States, Vascular Endothelial Growth Factor A, Visual Acuity